2025
Coronavirus Disease 2019 (COVID-19) Vaccination and Spontaneous Abortion
Sheth S, Vazquez-Benitez G, DeSilva M, Zhu J, Seburg E, Denoble A, Daley M, Getahun D, Klein N, Vesco K, Irving S, Nelson J, Williams J, Hambidge S, Donahue J, Lipkind H, Kharbanda E. Coronavirus Disease 2019 (COVID-19) Vaccination and Spontaneous Abortion. Obstetrics And Gynecology 2025, 146: 129-137. PMID: 40311142, PMCID: PMC12169859, DOI: 10.1097/aog.0000000000005904.Peer-Reviewed Original ResearchConceptsSpontaneous abortionVaccine Safety Datalink sitesLive birthsCase groupGestational ageCOVID-19 vaccineDose numberContinuous health plan enrollmentPregnancy start dateControl groupCase-control studyHealth plan enrollmentSafety of COVID-19 vaccinesConditional logistic regressionSingleton pregnanciesFetal deathPregnancy outcomesPrenatal visitEarly pregnancyMaternal agePregnancyVaccine exposureOutcome datePatientsPlan enrollmentClinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use
Fitzpatrick M, Behrens C, Hibler K, Parsons C, Kaplan C, Orso R, Parker L, Memmel L, Collins A, McNicholas C, Crane L, Hwang Y, Sutton E, Coleman J, Kuroki L, Harshberger K, Williams S, Jennings A, Buccini F, Gillis L, Novetsky A, Hawkes D, Saville M, Depel T, Aviki E, Sheth S, Conageski C. Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use. JAMA Network Open 2025, 8: e2511081. PMID: 40388167, PMCID: PMC12090030, DOI: 10.1001/jamanetworkopen.2025.11081.Peer-Reviewed Original ResearchConceptsCervical screeningPercentage agreementHigh-risk human papillomavirusScreening-eligible participantsSelf-collectionNonrandomized clinical trialDetection of high-risk human papillomavirusPositive percentage agreementMethod-comparison study designPrimary outcome measureHealth careUS womenSelf-collection methodDelayed screeningMain OutcomesAt-home settingClinical sensitivityOutcome measuresStudy designClinical sitesCervical dysplasiaStudy measuresDetection of high-grade cervical dysplasiaClinical trialsClinician-collected (CCExcess Mortality Rate in Black Children Since 1950 in the United States: A 70-Year Population-Based Study of Racial Inequalities.
Paternina-Caicedo A, Espinosa O, Sheth S, Hupert N, Saghafian S. Excess Mortality Rate in Black Children Since 1950 in the United States: A 70-Year Population-Based Study of Racial Inequalities. Annals Of Internal Medicine 2025, 178: 490-497. PMID: 40127447, DOI: 10.7326/annals-24-02794.Peer-Reviewed Original ResearchConceptsExcess mortality ratioMortality ratioBlack AmericansYears of potential lifePersistent excess mortalityEffect of health inequalityMortality rateWhite AmericansAge-standardized mortalityBlack infantsCenters for Disease Control and PreventionLife expectancyCalculated mortality ratesDisease Control and PreventionExcess mortality ratesControl and PreventionExcess mortality burdenUnited StatesHealth inequalitiesMortality dataMortality burdenExcess deathsExcess mortalityAbsolute life expectancyChildhood mortality
2024
Socio-economic factors associated with cancer stigma among apparently healthy women in two selected municipalities Nepal
Paneru B, Karmacharya A, Makaju S, Kafle D, Poudel L, Mali S, Timsina P, Shrestha N, Timalsena D, Chaudhary K, Bhandari N, Rai P, Shakya S, Spiegelman D, Sheth S, Stangl A, Eastment M, Shrestha A. Socio-economic factors associated with cancer stigma among apparently healthy women in two selected municipalities Nepal. PLOS ONE 2024, 19: e0301059. PMID: 39680514, PMCID: PMC11649127, DOI: 10.1371/journal.pone.0301059.Peer-Reviewed Original ResearchMeSH KeywordsAdultCitiesCross-Sectional StudiesFemaleHumansMiddle AgedNeoplasmsNepalSocial StigmaSocioeconomic FactorsConceptsCancer Stigma ScaleCancer stigmaMean stigma scoreGeneralized estimating equationsStigma scoresDomains of stigmaPublic health researchSocio-demographic factorsCross-sectional studyStigma ScaleMultivariate linear regressionHealthy womenLower educationHealth researchMarital statusCause of deathStigmaLow overall prevalenceEstimating equationsFemale populationLikert scalePrimary cause of deathOverall prevalenceOlder ageScoresRandomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)
Sheth S, Oh J, Bellone S, Siegel E, Greenman M, Mutlu L, McNamara B, Pathy S, Clark M, Azodi M, Altwerger G, Andikyan V, Huang G, Ratner E, Kim D, Iwasaki A, Levi A, Buza N, Hui P, Flaherty S, Schwartz P, Santin A. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147). Clinical Cancer Research 2024, 30: of1-of10. PMID: 38592381, DOI: 10.1158/1078-0432.ccr-23-3639.Peer-Reviewed Original ResearchConceptsRandomized phase II trialCD4/CD8 T cellsT cellsHPV clearanceArm BNo significant differenceClinical surveillanceRate of HPV clearanceSecondary outcomesPre-neoplastic cervical lesionsCervical intraepithelial neoplasiaT cell infiltrationT cell responsesSignificant differenceCIN3 patientsIntraepithelial neoplasiaArm ACervical lesionsImiquimod groupSurveillance armVaginal suppositoriesProspective trialsArm CHPV vaccinationImiquimod
2021
Patterns of recommended vaccine receipt among women ages 24–45 years: a cross-sectional analysis
Ellingson MK, Oliveira CR, Sheth SS, Sullivan EL, Torres A, Shapiro ED, Niccolai LM. Patterns of recommended vaccine receipt among women ages 24–45 years: a cross-sectional analysis. BMC Public Health 2021, 21: 1283. PMID: 34193100, PMCID: PMC8247221, DOI: 10.1186/s12889-021-11340-4.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccine receiptCross-sectional analysisHPV vaccineOngoing case-control studyReceipt of influenzaHealth care visitsCase-control studyWomen ages 24Quarter of adultsLogistic regression analysisCare visitsIndividual vaccinesHealthcare utilizationMultiple vaccinesVaccineAge 24White womenWomenDemographic characteristicsRegression analysisLower ratesInfluenzaReceiptPast year
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply